CoChat

Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques

Open access
Miranda, Mirela Costa de, Oliveira, Ana Carolina Maués de, Soares, Gabriel Junqueira, Batatinha, Júlio Américo Pereira, Latronico, Ana Claudia, Mendonca, Berenice Bilharinho, Bachega, Tania A. S. S. · 2026 · Frontiers in Endocrinology

The DOI matches its Crossref record; 104 of the 105 references it cites were found in a registry or an index, and 1 are not checked yet; 68 of the 129 sources its claims cite were checked for support.

Abstract

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is one of the most technically challenging monogenic conditions for molecular diagnosis, owing to the complex genomic architecture of the CYP21A2 locus and the extensive homology between the functional gene and its pseudogene. Over the past decades, diagnostic approaches have evolved from locus-specific assays, such as allele-specific polymerase chain reaction, to the combined use of Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA), which together constituted the historical gold-standard approach strategy capable of identifying pathogenic variants, deletions and chimeric alleles. Although short-read next-generation sequencing expanded variant detection and enabled simultaneous analysis of multiple adrenal genes, its performance remains limited within the RCCX region due to misalignment artefacts and inability to resolve complex structural rearrangements. Recently, long-read sequencing (LRS) has emerged as a single-platform technology capable of resolving the CYP21A2–CYP21A1P module, accurately detecting all variant classes and directly determining cis/trans phase.

Verified 2026-10-10 · 1 reference not checked yet

Overview

CoChat Summary

## TL;DR

This is a review of how molecular diagnosis of 21-hydroxylase deficiency (21-OHD) evolved from targeted, labor-intensive assays to Sanger/MLPA, short-read NGS, and now long-read sequencing. The paper argues that long-read sequencing is emerging as the best single-platform solution for the highly complex CYP21A2 locus, with studies reporting 100% sensitivity and specificity and improved genotype assignment in 14.6% of cases.

## Key findings

  • 21-OHD accounts for approximately 90–95% of CAH cases, and the disorder affects about 1:13,000 to 1:15,000 live births.
  • The review states that 90–95% of pathogenic CYP21A2 variants arise from intergenic recombination with the pseudogene; 70–75% are microconversion events and 20–25% are due to unequal meiotic crossover, while only 5–10% of small pathogenic variants occur independently of gene conversion.
  • Classical Sanger plus MLPA detects nearly all pathogenic alleles in most populations, with the text stating coverage of up to 98–99% of classical pathogenic alleles.
  • Long-read sequencing studies reported in the paper found 100% sensitivity and specificity in one workflow, and in a cohort of 322 probands it improved precise genotype assignment in 14.6% of cases.

## Methods

  • Narrative review synthesizing historical, technical, and clinical literature on molecular diagnosis of 21-OHD, focusing on CYP21A2 and the RCCX locus.
  • Compares diagnostic strategies across four broad classes: Southern blot/MLPA, targeted genotyping, Sanger sequencing, short-read NGS, and long-read sequencing.
  • Uses published studies and cohort reports to summarize analytical performance, genotype-phenotype correlation, and clinical implications for newborn screening and counseling.

## Limitations

  • The paper is a review and does not present a new primary dataset; this is evident from the text.
  • It states that reported functional activity values and genotype-phenotype concordance rates vary across studies because of heterogeneous experimental systems and populations; this is a limitation stated in the paper.
  • The text makes evident that evidence for long-read sequencing is still based on selected studies and implementation remains limited by DNA quality, cost, computational resources, and lack of routine standardization; these are stated as current constraints in the paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fendo.2026.1770274

Cites

104 of 105 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Locus RCCX: Schematic representation of the RCCX locus within the MHC region on chromosome 6p21.3, showing the modular arrangement RP–C4–CYP21A1P/CYP21A2–TNX. The functional CYP21A2 gene resides adjacent to its highly homologous pseudogene CYP21A1P, while flanking TNXA/TNXB genes predispose this region to non-allelic homologous recombination, leading to gene conversions, deletions, and chimeric alleles associated with congenital adrenal hyperplasia. Major CYP21A2 pathogenic variants derived from the CYP21A1P pseudogene across the exonic structure of CYP21A2: Schematic representation of the ten exons of the CYP21A2 gene indicating the location of the most frequent pseudogene-derived pathogenic variants associated with 21-hydroxylase deficiency, including p.(Pro31Leu), p.(Gly111fs), c.293-13C>G, p.(Ile173Asn), exon 6 cluster (p.[Ile237Asn], p.[Val238Glu], p.[Met240Lys]), p.(Val282Leu), p.(Leu308fs), p.(Gln319Ter), p.(Arg357Trp), and p.(Pro454Ser). These variants arise predominantly through microconversion events from CYP21A1P and represent the majority of disease-causing alleles worldwide. Adapted from Concolino et al (16). This schematic representation is not drawn to scale. Exon sizes, intergenic distances, and relative gene lengths are depicted for illustrative purposes only. Arrows indicate regions of gene conversion or recombination events within the RCCX locus and do not represent physical distances.
Figure 1 Locus RCCX: Schematic representation of the RCCX locus within the MHC region on chromosome 6p21.3, showing the modular arrangement RP–C4–CYP21A1P/CYP21A2–TNX. The functional CYP21A2 gene resides adjacent to its highly homologous pseudogene CYP21A1P, while flanking TNXA/TNXB genes predispose this region to non-allelic homologous recombination, leading to gene conversions, deletions, and chimeric alleles associated with congenital adrenal hyperplasia. Major CYP21A2 pathogenic variants derived from the CYP21A1P pseudogene across the exonic structure of CYP21A2: Schematic representation of the ten exons of the CYP21A2 gene indicating the location of the most frequent pseudogene-derived pathogenic variants associated with 21-hydroxylase deficiency, including p.(Pro31Leu), p.(Gly111fs), c.293-13C>G, p.(Ile173Asn), exon 6 cluster (p.[Ile237Asn], p.[Val238Glu], p.[Met240Lys]), p.(Val282Leu), p.(Leu308fs), p.(Gln319Ter), p.(Arg357Trp), and p.(Pro454Ser). These variants arise predominantly through microconversion events from CYP21A1P and represent the majority of disease-causing alleles worldwide. Adapted from Concolino et al (16). This schematic representation is not drawn to scale. Exon sizes, intergenic distances, and relative gene lengths are depicted for illustrative purposes only. Arrows indicate regions of gene conversion or recombination events within the RCCX locus and do not represent physical distances.CC BY · PubMed Central
Figure 2 Methodologies of DNA amplification or enrichment prior to CYP21A2 sequencing. (A) Traditional PCR-based amplification using three overlapping fragments covering the CYP21A2 gene, followed by Sanger sequencing; this approach relies on exon-specific primers and is vulnerable to allele dropout and pseudogene interference. (B) Long-range PCR strategy for Sanger sequencing, in which a single large amplicon spans the CYP21A2 gene and adjacent RCCX elements, extending toward the TNXB region to improve discrimination from the CYP21A1P pseudogene. (C) Long-amplicon design for long-read sequencing (LRS), enabling continuous sequencing across CYP21A2, CYP21A1P, C4 genes, and RCCX junctions, thereby allowing accurate detection of single-nucleotide variants, indels, and structural rearrangements. (D) Hybrid capture–based DNA enrichment for PCR-free LRS, in which fragmented genomic DNA is selectively captured by biotinylated probes and magnetic beads, allowing comprehensive analysis of the RCCX locus, including copy-number variations, gene conversions, and complex chimeric alleles. (D) Long-read sequencing enables direct haplotype phasing, allowing unambiguous determination of cis/trans configuration of CYP21A2 variants without the need for parental testing. This schematic representation is not drawn to scale.
Figure 2 Methodologies of DNA amplification or enrichment prior to CYP21A2 sequencing. (A) Traditional PCR-based amplification using three overlapping fragments covering the CYP21A2 gene, followed by Sanger sequencing; this approach relies on exon-specific primers and is vulnerable to allele dropout and pseudogene interference. (B) Long-range PCR strategy for Sanger sequencing, in which a single large amplicon spans the CYP21A2 gene and adjacent RCCX elements, extending toward the TNXB region to improve discrimination from the CYP21A1P pseudogene. (C) Long-amplicon design for long-read sequencing (LRS), enabling continuous sequencing across CYP21A2, CYP21A1P, C4 genes, and RCCX junctions, thereby allowing accurate detection of single-nucleotide variants, indels, and structural rearrangements. (D) Hybrid capture–based DNA enrichment for PCR-free LRS, in which fragmented genomic DNA is selectively captured by biotinylated probes and magnetic beads, allowing comprehensive analysis of the RCCX locus, including copy-number variations, gene conversions, and complex chimeric alleles. (D) Long-read sequencing enables direct haplotype phasing, allowing unambiguous determination of cis/trans configuration of CYP21A2 variants without the need for parental testing. This schematic representation is not drawn to scale.CC BY · PubMed Central

Verification

Claims the paper makes

44 Valid · 3 Not valid · 15 Not checked · 19 Own results and interpretations

29 more claims · 15 with their cited sources checked

Create a free account to see all 81 claims and to verify the 4 references still open.

See all claims — free account
  • It may state two separate claims as one. 45
  • Probably not a substantial claim. 2

Create a free account to see these claims.

Citations

Cites

Show all 105 references

Cited by

See all 2

Metadata

Authors
Miranda, M. C. D., Oliveira, A. C. M. D., Soares, G. J., Batatinha, J. A. P., Latronico, A. C., Mendonca, B. B., & Bachega, T. A. S. S.
Affiliations
  • Laboratório de Hormônios e Genética Molecular - LIM/42, Unidade de Desenvolvimento, Disciplina de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo
  • Universidade de São Paulo (BR)
Venue
Frontiers in Endocrinology
Published
2026-04-02
Volume
17
Pages
1770274-1770274
ISSN
1664-2392 (ISSN-L)
OpenAlex
W7147679433
Cited by
2
References
91
Citations by year
2026: 2
FWCI
1.65
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/, 23/11168-1, 88887, 19/26780-9)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
21-hydroxylase deficiency, congenital adrenal hyperplasia, CYP21A2, long-read sequencing, multiplex ligation-dependent probe amplification, allele-specific PCR, structural rearrangement, newborn screening, salt-wasting phenotype, genetic counseling
MeSH terms
Adrenal Hyperplasia, Congenital, Humans, Steroid 21-Hydroxylase, Genomics, Molecular Diagnostic Techniques, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques. https://app.cochat.ai/papers/10.3389/fendo.2026.1770274
The paper
Miranda, M. C. D., Oliveira, A. C. M. D., Soares, G. J., Batatinha, J. A. P., Latronico, A. C., Mendonca, B. B., & Bachega, T. A. S. S. (2026). Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1770274

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.